AZN AstraZeneca PLC

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals  | NASDAQ, MegaCap, ObesityDrugs |  Last Price: 208.62 | 2026-02-19 | Atrp: 2.92

Wed 28 Jan 2026 to Wed 04 Feb 2026: Score -1

Metric		Previous	New	Change	Interpretation
❌	Price Sales TTM	5.0994	10.05	▲ 97.08%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
❌	Short Percent	0.35%	0.4%	▲ 14.29%	Bearish. Lower is better. Moderate increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
❌	Short Ratio	2.18	2.25	▲ 3.21%	Bearish. Lower is better. Slight decline
✅	PEG Ratio	1.1114	1.0785	▼ -2.96%	Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate
✅	Forward PE	18.797	18.2149	▼ -3.1%	Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings
✅	Price Book MRQ	6.4595	6.2683	▼ -2.96%	Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter
✅	Enterprise Value/Revenue	5.4834	5.4279	▼ -1.01%	Bullish. Lower is better. Slight improvement Enterprise value divided by revenue
✅	Enterprise Value/EBITDA	17.7529	17.573	▼ -1.01%	Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation
✅	Wall Street Target Price	99.5918	113.5027	▲ 13.97%	Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance Analysts' consensus target price for the stock

Wed 21 Jan 2026 to Wed 28 Jan 2026: Score -11

Metric		Previous	New	Change	Interpretation
❌	PEG Ratio	1.0334	1.1114	▲ 7.55%	Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate
❌	Forward PE	17.452	18.797	▲ 7.71%	Bearish. Lower is better. Slight decline Stock price divided by expected future earnings
❌	Price Sales TTM	4.7975	5.0994	▲ 6.29%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
❌	Price Book MRQ	6.0771	6.4595	▲ 6.29%	Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter
❌	Enterprise Value/Revenue	5.2587	5.4834	▲ 4.27%	Bearish. Lower is better. Slight decline Enterprise value divided by revenue
❌	Enterprise Value/EBITDA	17.0253	17.7529	▲ 4.27%	Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation
✅	Enterprise Value	$305.67B	$316.02B	▲ 3.39%	Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash

Wed 14 Jan 2026 to Wed 21 Jan 2026: Score 9

Metric		Previous	New	Change	Interpretation
✅	PEG Ratio	1.0859	1.0334	▼ -4.83%	Bullish. Lower is better. Slight decrease, improving the value relative to growth P/E ratio adjusted for growth rate
✅	Forward PE	18.3486	17.452	▼ -4.89%	Bullish. Lower is better. Slight improvement Stock price divided by expected future earnings
✅	Price Sales TTM	5.0413	4.7975	▼ -4.84%	Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales Stock price divided by revenue per share over the trailing twelve months
✅	Price Book MRQ	6.3859	6.0771	▼ -4.84%	Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception Stock price divided by book value per share for the most recent quarter
✅	Enterprise Value/Revenue	5.4508	5.2587	▼ -3.52%	Bullish. Lower is better. Slight improvement Enterprise value divided by revenue
✅	Enterprise Value/EBITDA	17.6473	17.0253	▼ -3.52%	Bullish. Lower is better. Slight improvement Enterprise value to earnings before interest, taxes, depreciation
❌	Enterprise Value	$316.84B	$305.67B	▼ -3.52%	Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments Market capitalization plus debt minus cash

Tue 06 Jan 2026 to Wed 14 Jan 2026: Score -13

Metric		Previous	New	Change	Interpretation
❌	Short Ratio	1.43	2.18	▲ 52.45%	Bearish. Lower is better. Substantial decline
❌	Short Percent	0.27%	0.35%	▲ 29.63%	Bearish. Lower is better. Significant increase; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short
❌	PEG Ratio	1.0521	1.0859	▲ 3.21%	Bearish. Lower is better. Slight increase, worsening the value relative to growth P/E ratio adjusted for growth rate
❌	Forward PE	17.7936	18.3486	▲ 3.12%	Bearish. Lower is better. Slight decline Stock price divided by expected future earnings
❌	Price Sales TTM	4.8658	5.0413	▲ 3.61%	Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales Stock price divided by revenue per share over the trailing twelve months
❌	Price Book MRQ	6.1872	6.3859	▲ 3.21%	Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception Stock price divided by book value per share for the most recent quarter
❌	Enterprise Value/Revenue	5.3044	5.4508	▲ 2.76%	Bearish. Lower is better. Slight decline Enterprise value divided by revenue
❌	Enterprise Value/EBITDA	17.1733	17.6473	▲ 2.76%	Bearish. Lower is better. Slight decline Enterprise value to earnings before interest, taxes, depreciation
✅	Enterprise Value	$308.33B	$316.84B	▲ 2.76%	Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments Market capitalization plus debt minus cash

Sun 21 Dec 2025 to Tue 06 Jan 2026: Score 5

Metric		Previous	New	Change	Interpretation
✅	Short Ratio	1.85	1.43	▼ -22.7%	Bullish. Lower is better. Significant improvement
✅	Short Percent	0.3%	0.27%	▼ -10%	Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge Percentage of shares sold short